Controversies in geriatric medicineSarcopenia: A useful paradigm for physical frailty
Introduction
The concepts and definitions of frailty and sarcopenia are being actively revised in recent times [1], [2], [3]. Initial definitions of frailty considered it as a synonymous of disability, multimorbidity or extreme old age, being only a subjective perception by the clinician [4]. During the last decade the concept of frailty started to approach some consensus: frailty is a biological syndrome of decreased reserve and resistance to stressors, resulting from cumulative declines across multiple physiologic systems and causing vulnerability to adverse outcomes [5]. However, this concept has proved elusive when it is brought to clinical practice. Frailty is a complex and multidimensional construct, which explains the problems involved in its working definition and operationalization in clinical research and practice [6]. Current thinking is that frailty cannot be limited to a physical paradigm; psychological, cognitive, emotional, social and spiritual factors contribute to frailty and need to be taken into account in its definition [1].
Research on physical frailty is far more advanced than research on other aspects of frailty. A phenotypical approach to physical frailty has been introduced in clinical practice [5], although it has not shown full success in the prediction of outcomes [7], [8]. An alternative model of accumulation of deficits has also been used [9], [10]. None of these approaches seem to yield similar results in clinical practice [11], which is again confusing to our present understanding of physical frailty. What do these indicators of frailty really measure?
Physical frailty is strongly linked to muscle mass and function. In 1988, Irwin H. Rosenberg stated that “over the decades of life, there is probably no decline in structure and function more dramatic than the decline in lean body mass or muscle mass” [12]. He postulated that this decline has a negative impact on ambulation, mobility, breathing, energy intake, overall nutrient intake and status and independence. He suggested giving it a name: sarcopenia. The definition of sarcopenia has also been evolving since it was named, starting from muscle mass and moving toward muscle strength and function, physical performance and impaired outcomes [2], [13], [14]. One of the most recent definitions states that sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes, such as physical disability, poor quality of life and death [14]. Many would argue that the whole picture depicted here for sarcopenia is not far from the current phenotypic definition of frailty.
A careful examination of the most popular present definitions of sarcopenia and physical frailty shows that they share many common points. For instance, three out of five elements of Fried's phenotypical definition of physical frailty (shrinking, weakness, slowness) [5] are part of the EWGSOP definition of sarcopenia [14]. However, from a physiological and clinical perspective, sarcopenia is closer to an organ function (skeletal muscle) than frailty, and may be easier to apply in clinical practice. Drug regulatory agencies consider frailty a problematic indication for drug approval [15] and may find sarcopenia (broadly viewed as “muscle insufficiency”, which is closer to most organs and system disease pathways) a simpler construct.
In this paper, we will review how the concept of geriatric syndromes has changed, we will explore some syndromic approaches to frailty and sarcopenia, and we will argue that sarcopenia is the major determinant of physical frailty. We will, thus, propose that sarcopenia is a useful paradigm for physical frailty.
Section snippets
The evolving concept of geriatric syndromes
One of the problems that are complicating the development and validation of the concepts of frailty and sarcopenia is that both need to be distinguished from normal age-related changes and from other age-related diseases and conditions. In fact, recent literature shows that both sarcopenia and frailty may be best understood when considered as geriatric syndromes [16], [17], [18].
The term “geriatric syndrome” has been commonly used in the geriatric literature for decades to define complex
A syndromic approach to sarcopenia and frailty
Being said that, frailty can be well understood as a geriatric syndrome. Frailty, and even isolated physical frailty, does not seem to fit into a single disease category, or to be only usual ageing. In specific life environments/conditions, it can be the consequence of a single disease and of multimorbid conditions [22]. It can be identified or defined by observing or measuring different clinical features, being the clinical manifestation of multiple underlying diseases and complex conditions.
Sarcopenia, the major determinant of physical frailty
Older definitions of sarcopenia, based only on absolute or relative muscle mass, are losing relevance, as it is now clear that muscle mass, strength and function do not run parallel. The concept of frailty developed in this arena, pointing out that functional aspects were more relevantly linked to relevant health outcomes than muscle mass [34]. However, new definitions of sarcopenia have moved away from the “muscle mass only” concept to include muscle function and physical performance.
As
Disclosure of interest
The authors have not supplied their declaration of conflict of interest.
References (39)
- et al.
Toward a definition of sarcopenia
Clin Geriatr Med
(2011) - et al.
The frailty dilemma. Review of the predictive accuracy of major frailty scores
Eur J Intern Med
(2012) - et al.
The mortality rate as a function of accumulated deficits in a frailty index
Mech Ageing Dev
(2002) Summary comments: epidemiological and methodological problems in determining nutritional status of older persons
Clin Nutr
(1989)- et al.
Sarcopenia with limited mobility: an international consensus
J Am Med Dir Assoc
(2011) - et al.
Predictors of institution admission in the year following acute hospitalisation of elderly people
J Nutr Health Aging
(2011) - et al.
Frailty syndrome diagnosed according to the study of osteoporotic fractures (SOF) criteria and adverse health outcomes among community-dwelling older outpatients in Italy. A one-year prospective cohort study
Arch Gerontol Geriatr
(2012) - et al.
The loss of muscle mass and sarcopenia: non hormonal intervention
Exp Gerontol
(2011) - et al.
Chronology of age-related disease definitions: osteoporosis and sarcopenia
Ageing Res Rev
(2012) - et al.
Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women's Health and Aging Study (WHAS) II
Bone
(2011)
Sarcopenia and frailty: a clinician's controversial point of view
Exp Gerontol
Frailty in the elderly: contributions of sarcopenia and visceral protein depletion
Metabolism
Editorial: implementing frailty into clinical practice: we cannot wait
J Nutr Health Aging
Definitions of sarcopenia
Toward an understanding of frailty
Ann Intern Med
Frailty in older adults: evidence for a phenotype
J Gerontol A Biol Sci Med Sci
Frailty: an emerging research and clinical paradigm–issues and controversies
J Gerontol A Biol Sci Med Sci
The identification of frailty: a systematic literature review
J Am Geriatr Soc
Cited by (57)
Cystatin C and Creatinine Concentrations Are Uninformative Biomarkers of Sarcopenia: A Cross-Sectional NHANES Study
2023, Journal of Renal NutritionDefining and diagnosing sarcopenia: Is the glass now half full?
2023, Metabolism: Clinical and ExperimentalVascular endothelial dysfunction may be an early predictor of physical frailty and sarcopenia: A meta-analysis of available data from observational studies
2021, Experimental GerontologyCitation Excerpt :Frailty is an emergent public health issue, particularly in the older population and is a multifactorial syndrome which is associated with functional and cognitive decline (Morley et al., 2013). Sarcopenia, which is characterized by unintentional loss of skeletal muscle mass and function with advancing age is a major determinant of frailty, disability and mortality in the older adult (Cruz-Jentoft and Michel, 2013). Frailty and weakness of skeletal muscle mass of older adults are associated with poor health-outcomes including disability, hospitalization, and increased mortality and morbidity with significantly higher healthcare utilization and related economic cost (Cesari et al., 2016).
Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management
2019, Journal of Nutrition, Health and AgingDepressive symptoms and muscle weakness: A two-way relation?
2018, Experimental GerontologySarcopenia
2019, The Lancet